Genetic Alterations of the Thrombopoietin/MPL/JAK2 Axis Impacting Megakaryopoiesis
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Genetic Alterations of the Thrombopoietin/MPL/JAK2 Axis Impacting Megakaryopoiesis
Authors
Keywords
-
Journal
Frontiers in Endocrinology
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2017-09-12
DOI
10.3389/fendo.2017.00234
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The lung is a site of platelet biogenesis and a reservoir for haematopoietic progenitors
- (2017) Emma Lefrançais et al. NATURE
- An incomplete trafficking defect to the cell-surface leads to paradoxical thrombocytosis for human and murine MPL P106L
- (2016) F. Favale et al. BLOOD
- Activation of the thrombopoietin receptor by mutant calreticulin in CALR-mutant myeloproliferative neoplasms
- (2016) M. Araki et al. BLOOD
- Calreticulin mutant mice develop essential thrombocythemia that is ameliorated by the JAK inhibitor ruxolitinib
- (2016) K Shide et al. LEUKEMIA
- JAK2V617F-mutant megakaryocytes contribute to hematopoietic stem/progenitor cell expansion in a model of murine myeloproliferation
- (2016) H Zhan et al. LEUKEMIA
- A dominant gain-of-function mutation in universal tyrosine kinase SRC causes thrombocytopenia, myelofibrosis, bleeding, and bone pathologies
- (2016) Ernest Turro et al. Science Translational Medicine
- Mutant Calreticulin Requires Both Its Mutant C-terminus and the Thrombopoietin Receptor for Oncogenic Transformation
- (2016) S. Elf et al. Cancer Discovery
- Whole-exome sequencing identifies novel MPL and JAK2 mutations in triple-negative myeloproliferative neoplasms
- (2015) J. D. Milosevic Feenstra et al. BLOOD
- Thrombopoietin receptor activation by myeloproliferative neoplasm associated calreticulin mutants
- (2015) I. Chachoua et al. BLOOD
- Calreticulin mutants in mice induce an MPL-dependent thrombocytosis with frequent progression to myelofibrosis
- (2015) C. Marty et al. BLOOD
- Presence of atypical thrombopoietin receptor (MPL) mutations in triple-negative essential thrombocythemia patients
- (2015) X. Cabagnols et al. BLOOD
- His499Regulates Dimerization and Prevents Oncogenic Activation by Asparagine Mutations of the Human Thrombopoietin Receptor
- (2015) Emilie Leroy et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Oncogenic activation of MPL/thrombopoietin receptor by 17 mutations at W515: implications for myeloproliferative neoplasms
- (2015) J-P Defour et al. LEUKEMIA
- Distinct routes of lineage development reshape the human blood hierarchy across ontogeny
- (2015) F. Notta et al. SCIENCE
- Type 1 versus Type 2 calreticulin mutations in essential thrombocythemia: A collaborative study of 1027 patients
- (2014) Ayalew Tefferi et al. AMERICAN JOURNAL OF HEMATOLOGY
- A novel activating, germline JAK2 mutation, JAK2R564Q, causes familial essential thrombocytosis
- (2014) S. L. Etheridge et al. BLOOD
- JAK2V617F homozygosity drives a phenotypic switch in myeloproliferative neoplasms, but is insufficient to sustain disease
- (2014) J. Li et al. BLOOD
- JAK2 and MPL protein levels determine TPO-induced megakaryocyte proliferation vs differentiation
- (2014) R. Besancenot et al. BLOOD
- The thrombopoietin receptor P106L mutation functionally separates receptor signaling activity from thrombopoietin homeostasis
- (2014) C. Stockklausner et al. BLOOD
- Genetic studies reveal an unexpected negative regulatory role for Jak2 in thrombopoiesis
- (2014) S. C. Meyer et al. BLOOD
- Germ-line JAK2 mutations in the kinase domain are responsible for hereditary thrombocytosis and are resistant to JAK2 and HSP90 inhibitors
- (2014) C. Marty et al. BLOOD
- Thrombopoietin from beginning to end
- (2014) Ian S. Hitchcock et al. BRITISH JOURNAL OF HAEMATOLOGY
- Phosphorylated c-Mpl tyrosine 591 regulates thrombopoietin-induced signaling
- (2014) Veena Sangkhae et al. EXPERIMENTAL HEMATOLOGY
- Functional characterization of c-Mpl ectodomain mutations that underlie congenital amegakaryocytic thrombocytopenia
- (2014) Leila N. Varghese et al. GROWTH FACTORS
- Selective deletion of Jak2 in adult mouse hematopoietic cells leads to lethal anemia and thrombocytopenia
- (2014) J. Grisouard et al. HAEMATOLOGICA
- Differential association of calreticulin type 1 and type 2 mutations with myelofibrosis and essential thrombocytemia: relevance for disease evolution
- (2014) X Cabagnols et al. LEUKEMIA
- Type 1 vs type 2 calreticulin mutations in primary myelofibrosis: differences in phenotype and prognostic impact
- (2014) A Tefferi et al. LEUKEMIA
- The Ashwell-Morell receptor regulates hepatic thrombopoietin production via JAK2-STAT3 signaling
- (2014) Renata Grozovsky et al. NATURE MEDICINE
- Mpl expression on megakaryocytes and platelets is dispensable for thrombopoiesis but essential to prevent myeloproliferation
- (2014) A. P. Ng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A novel germlineJAK2mutation in familial myeloproliferative neoplasms
- (2013) Elisa Rumi et al. AMERICAN JOURNAL OF HEMATOLOGY
- Exome sequencing reveals a thrombopoietin ligand mutation in a Micronesian family with autosomal recessive aplastic anemia
- (2013) M. J. Dasouki et al. BLOOD
- Depletion of Jak2V617F myeloproliferative neoplasm-propagating stem cells by interferon- in a murine model of polycythemia vera
- (2013) A. Mullally et al. BLOOD
- JAK2V617F expression in mice amplifies early hematopoietic cells and gives them a competitive advantage that is hampered by IFN
- (2013) S. Hasan et al. BLOOD
- SH2B3 (LNK)mutations from myeloproliferative neoplasms patients have mild loss of function against wild type JAK2 and JAK2 V617F
- (2013) Maya Koren-Michowitz et al. BRITISH JOURNAL OF HAEMATOLOGY
- Infrequent occurrence of mutations in the PH domain of LNK in patients with JAK2 mutation-negative 'idiopathic' erythrocytosis
- (2013) A. Spolverini et al. HAEMATOLOGICA
- Somatic CALR Mutations in Myeloproliferative Neoplasms with Nonmutated JAK2
- (2013) J. Nangalia et al. NEW ENGLAND JOURNAL OF MEDICINE
- Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms
- (2013) Thorsten Klampfl et al. NEW ENGLAND JOURNAL OF MEDICINE
- Crystal structures of the JAK2 pseudokinase domain and the pathogenic mutant V617F
- (2012) Rajintha M Bandaranayake et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- GermlineJAK2Mutation in a Family with Hereditary Thrombocytosis
- (2012) Adam J. Mead et al. NEW ENGLAND JOURNAL OF MEDICINE
- Role of the adaptor protein LNK in normal and malignant hematopoiesis
- (2012) S Gery et al. ONCOGENE
- Possible new LNK mutations in myeloproliferative neoplasms
- (2011) Jung-Sook Ha et al. AMERICAN JOURNAL OF HEMATOLOGY
- Orientation-specific signalling by thrombopoietin receptor dimers
- (2011) Judith Staerk et al. EMBO JOURNAL
- LNK can also be mutated outside PH and SH2 domains in myeloproliferative neoplasms with and without V617FJAK2 mutation
- (2011) C. Hurtado et al. LEUKEMIA RESEARCH
- Congenital amegakaryocytic thrombocytopenia
- (2011) Amy E. Geddis PEDIATRIC BLOOD & CANCER
- Novel mutations in the inhibitory adaptor protein LNK drive JAK-STAT signaling in patients with myeloproliferative neoplasms
- (2010) S. T. Oh et al. BLOOD
- Conditional expression of heterozygous or homozygous Jak2V617F from its endogenous promoter induces a polycythemia vera-like disease
- (2010) H. Akada et al. BLOOD
- F104S c-Mpl responds to a transmembrane domain−binding thrombopoietin receptor agonist: Proof of concept that selected receptor mutations in congenital amegakaryocytic thrombocytopenia can be stimulated with alternative thrombopoietic agents
- (2010) Norma E. Fox et al. EXPERIMENTAL HEMATOLOGY
- Identification of the Residues in the Extracellular Domain of Thrombopoietin Receptor Involved in the Binding of Thrombopoietin and a Nuclear Distribution Protein (Human NUDC)
- (2010) Wei-Min Chen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Calreticulin, a multi-process calcium-buffering chaperone of the endoplasmic reticulum
- (2009) Marek Michalak et al. BIOCHEMICAL JOURNAL
- Ubiquitination and degradation of the thrombopoietin receptor c-Mpl
- (2009) S. J. Saur et al. BLOOD
- Frequent CBL mutations associated with 11q acquired uniparental disomy in myeloproliferative neoplasms
- (2009) F. H. Grand et al. BLOOD
- Compound heterozygous c-Mpl mutations in a child with congenital amegakaryocytic thrombocytopenia: Functional characterization and a review of the literature
- (2009) Norma E. Fox et al. EXPERIMENTAL HEMATOLOGY
- Evidence for a founder effect of the MPL-S505N mutation in eight Italian pedigrees with hereditary thrombocythemia
- (2009) K. Liu et al. HAEMATOLOGICA
- Incomplete restoration of Mpl expression in the mpl-/- mouse produces partial correction of the stem cell-repopulating defect and paradoxical thrombocytosis
- (2008) B. J. Lannutti et al. BLOOD
- MPL mutations in myeloproliferative disorders: analysis of the PT-1 cohort
- (2008) P. A. Beer et al. BLOOD
- Megakaryocyte endomitosis is a failure of late cytokinesis related to defects in the contractile ring and Rho/Rock signaling
- (2008) L. Lordier et al. BLOOD
- Pronounced thrombocytosis in transgenic mice expressing reduced levels of Mpl in platelets and terminally differentiated megakaryocytes
- (2008) R. Tiedt et al. BLOOD
- Functional analysis of single amino-acid mutations in the thrombopoietin-receptor Mpl underlying congenital amegakaryocytic thrombocytopenia
- (2008) Marloes R. Tijssen et al. BRITISH JOURNAL OF HAEMATOLOGY
- Familial thrombocytosis caused by the novel germ-line mutation p.Pro106Leu in theMPLgene
- (2008) El-Harith Abdelghaffar El-Harith et al. BRITISH JOURNAL OF HAEMATOLOGY
- New mutations of MPL in primitive myelofibrosis: only the MPL W515 mutations promote a G1/S-phase transition
- (2008) R Chaligné et al. LEUKEMIA
- Romiplostim
- (2008) Douglas B. Cines et al. NATURE REVIEWS DRUG DISCOVERY
- Ratio of mutant JAK2-V617F to wild-type Jak2 determines the MPD phenotypes in transgenic mice
- (2007) R. Tiedt et al. BLOOD
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now